I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Vitte, Jeremie
39
results:
english X
Search for persons
X
Format
Online (39)
Mediatypes
Articles (Online) (19)
OpenAccess-fulltext (20)
Sorted by: Year
Sorted by: Relevance
?
1
Imaging as an early biomarker to predict sensitivity to eve..:
Nghiemphu, Phioanh Leia
;
Vitte, Jeremie
;
Dombi, Eva
...
Journal of Neuro-Oncology. 167 (2024) 2 - p. 339-348 , 2024
Link:
https://doi.org/10.1007/..
?
2
Gene-targeted therapy for neurofibromatosis and schwannomat..:
Staedtke, Verena
;
Anstett, Kara
;
Bedwell, David
...
Clinical Trials. , 2023
Link:
https://doi.org/10.1177/..
?
3
Cellular mechanisms of heterogeneity in NF2-mutant schwanno..:
Chiasson-MacKenzie, Christine
;
Vitte, Jeremie
;
Liu, Ching-Hui
...
Nature Communications. 14 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
4
RBIO-11. BASAL BCL-2-INTERACTING MEDIATOR OF CELL DEATH (BI..:
Harary, Maya
;
Fernandez, Elizabeth
;
Casaos, Joshua
...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v258-v258 , 2023
Link:
https://doi.org/10.1093/..
?
5
Cellular mechanisms of heterogeneity in NF2-mutant schwanno..:
Christine Chiasson-MacKenzie
;
Jeremie Vitte
;
Ching-Hui Liu
...
https://doi.org/10.1038/s41467-023-37226-0. , 2023
Link:
https://doi.org/10.1038/..
?
6
Cellular mechanisms of heterogeneity in NF2-mutant schwanno..:
Chiasson-MacKenzie, Christine
;
Vitte, Jeremie
;
Liu, Ching-Hui
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030849/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
7
EXTH-87. DECITABINE POTENTIATES MENINGIOMA IMMUNOTHERAPY TA..:
Sun, Matthew
;
Orpilla, Joey
;
Contreras, Erick
...
Neuro-Oncology. 24 (2022) Supplement_7 - p. vii229-vii229 , 2022
Link:
https://doi.org/10.1093/..
?
8
MODL-13. GENETICALLY ENGINEERED PIG MODEL OF RHABDOID TUMOR..:
Na, Brian
;
Rubinstein, C Dustin
;
Meudt, Jennifer J
...
Neuro-Oncology. 22 (2020) Supplement_3 - p. iii413-iii413 , 2020
Link:
https://doi.org/10.1093/..
?
9
MODL-13. GENETICALLY ENGINEERED PIG MODEL OF RHABDOID TUMOR..:
Na, Brian
;
Rubinstein, C Dustin
;
Meudt, Jennifer J
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715455/. , 2020
Link:
http://www.ncbi.nlm.nih...
?
10
Preclinical assessment of MEK1/2 inhibitors for neurofibrom..:
Fuse, Marisa A
;
Dinh, Christine T
;
Vitte, Jeremie
...
Neuro-Oncology. 21 (2019) 4 - p. 486-497 , 2019
Link:
https://doi.org/10.1093/..
?
11
TMOD-15. SPATIOTEMPORAL LOSS OF SMARCB1 IN EARLY NEURAL CRE..:
Vitte, Jeremie
;
Gao, Fuying
;
Coppola, Giovanni
..
Neuro-Oncology. 21 (2019) Supplement_2 - p. ii124-ii124 , 2019
Link:
https://doi.org/10.1093/..
?
12
TMOD-23. PRECLINICAL DRUG EVALUATION IN A GENETICALLY ENGIN..:
Osum, Sara
;
Stemmer-Rachamimov, Anat
;
Widemann, Brigitte
...
Neuro-Oncology. 21 (2019) Supplement_6 - p. vi267-vi267 , 2019
Link:
https://doi.org/10.1093/..
?
13
Genetically engineered minipigs model the major clinical fe..:
Isakson, Sara H.
;
Rizzardi, Anthony E.
;
Coutts, Alexander W.
...
Communications Biology. 1 (2018) 1 - p. , 2018
Link:
https://doi.org/10.1038/..
?
14
Genetically engineered minipigs model the major clinical fe..:
Isakson, Sara H
;
Rizzardi, Anthony E
;
Coutts, Alexander W
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168575/. , 2018
Link:
http://www.ncbi.nlm.nih...
?
15
Timing of Smarcb1 and Nf2 inactivation determines schwannom..:
Vitte, Jeremie
;
Gao, Fuying
;
Coppola, Giovanni
..
Nature Communications. 8 (2017) 1 - p. , 2017
Link:
https://doi.org/10.1038/..
1-15